AlloSource was awarded U.S. Patent No. 9,186,253, Cartilage mosaic compositions and methods, for its ProChondrix® Cartilage Restoration Matrix allograft product.
As a cellular 3D fresh cartilage matrix format, ProChondrix provides live functional cells and biological components to support repair and regeneration of damaged cartilage tissues.
The new patent follows three secured at the close of 2015 for AlloSource:
- U.S. Patent No. 9,192,695, Allografts combined with tissue derived stem cells for bone healing, relating to AlloStem® Cellular Bone Allograft
- U.S. Patent No. 9,168,140, Perforated osteochondral allograft compositions, addressing donated osteochondral tissue with a bone and cartilage layer perforated with small holes to allow for cellular migration and osteochondral repair
- U.S. Patent No. 9,186,380, Minced cartilage systems and methods, covering donated cartilage tissue processed to include small particles of cartilage containing living chondrocytes